• Projects
    • Technology Platform
    • Pipeline
    • Stem Cell Therapy
    • Targeted cancer therapy
    • Indications
    • Publications
  • Investors
    • Share Information
    • Financial Reports
    • Financial Calendar
    • Analyses
    • Share issues
    • Management & Board
    • Corporate Governance
    • General Meetings
    • IR Contact / Certified Adviser
  • Media
    • Press Releases
    • Xintelling – Newsletter
    • Videos
    • Xintela in the news
    • Events
  • About Xintela
  • Contact
  • Svenska
  • SV
  • SV

Contact Info

Xintela AB
Medicon Village
223 81 Lund, Sweden
+46 46 275 65 00
info@xintela.se

Reg. No: 556780-3480
VAT No: SE556780348001
Privacy Policy

Visitors address

Scheeletorget 1, Lund

Business & administration

Evy Lundgren-Åkerlund CEO
evy@xintela.se

IR & Media

evy@xintela.se

Subscribe to press releases, reports, newsletters and analyses.

© 2026 Xintela AB | All Rights Reserved

  • Projects
    • Technology Platform
    • Pipeline
    • Stem cell therapy
    • Targeted cancer therapy
    • Indications
    • Publications
  • Investors
    • Share Information
    • Financial Reports
    • Financial Calendar
    • Analyses
    • Share issues
    • Management & Board
    • Corporate Governance
    • General Meetings
    • IR-contact / Certified Adviser
  • Media
    • Press Releases
    • Xintelling – Newsletter
    • Videos
    • Xintela in the news
    • Events
  • About Xintela
  • Contact
  • Research & Development
    • Integrin α10β1
    • Pipeline
    • TARG9
    • TARG10
    • Cancer Indications
  • About Targinta
    • Management & Board
    • Business Development
    • Invest
  • Contact